Modified siNA Composition for Stable Target Cell Delivery
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing RNAi therapy faces challenges in effectively delivering siRNA to target cells and maintaining the stability of siRNA molecules.
Innovation Solution
The development of short interfering nucleic acid (siNA) molecules with modified nucleobases, optimized nucleotide combinations, lengths, and modification patterns, including 2′-O-methyl and 2′-fluoro nucleotides, phosphorothioate and mesyl phosphoramidate internucleoside linkages, and 5′-stabilized end caps, to enhance delivery and stability.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If modified nucleobases and optimized nucleotide combinations are used in siNA molecules, then delivery efficiency and stability are improved, but molecular complexity increases
Solution Approach 1:
The patent applies local quality by introducing specific modifications at particular positions within the siNA molecule. Modified nucleobases are placed at specific locations (e.g., 2′-O-methyl and 2′-fluoro nucleotides at defined positions) to enhance delivery and stability without modifying the entire molecule. This localized approach improves performance while controlling complexity by only altering necessary regions.
Solution Approach 2:
The siNA molecules are constructed as composite structures combining different nucleotide types (2′-O-methyl nucleotides, 2′-fluoro nucleotides, phosphorothioate linkages, mesyl phosphoramidate linkages) in specific patterns. This composite approach allows each component to contribute specific properties (stability, delivery, immunomodulation) while achieving overall enhanced performance through synergistic combination.
2Stability of the object's composition
If modified nucleobases and optimized nucleotide combinations are used in siNA molecules, then stability against degradation is improved, but molecular complexity increases
Solution Approach 1:
Stability enhancements are achieved through localized modifications at specific positions rather than uniform modification throughout the molecule. For example, phosphorothioate linkages are introduced at particular internucleoside positions and 2′-fluoro nucleotides are placed at specific locations to provide targeted protection against degradation while maintaining overall molecular simplicity.
Solution Approach 2:
The patent employs preemptive protective measures by incorporating stable nucleotide modifications and protective linkages before degradation can occur. The 2′-O-methyl and 2′-fluoro nucleotides, along with phosphorothioate and mesyl phosphoramidate linkages, are built into the molecular structure in advance to prevent nuclease degradation and improve serum stability before the molecule encounters degrading enzymes in biological systems.
3Ease of operation
If optimized nucleotide lengths and modification patterns are used, then target cell penetration is enhanced, but manufacturing complexity increases
Solution Approach 1:
The patent optimizes specific parameters including nucleotide length (19-27 nucleotides), modification patterns (specific positions of 2′-O-methyl and 2′-fluoro nucleotides), and linkage types (phosphorothioate and mesyl phosphoramidate at defined positions). These parameter optimizations enhance target cell penetration through improved cellular uptake and endosomal escape while maintaining manageable manufacturing complexity through standardized synthesis protocols.
Data Source
AI summary
Described are short interfering nucleic acid (siNA) molecules comprising modified nucleotides, compositions, and methods and uses thereof.